Patient Attitudes and Preferences Regarding Treatment: GH Therapy for Childhood Short Stature

This paper examines the role of parents’ attitudes and preferences regarding growth hormone therapy for childhood short stature. Four main questions are addressed. First, what are the demographic characteristics of families seeking medical advice for their child’s short stature? Second, what are parents’ attitudes towards short stature? Third, what are parents’ treatment preferences (i.e. what characteristics of growth treatments are important to parents)? Finally, how do the attitudes of parents affect physician decision making? Several studies are reviewed and data are presented to answer these questions.

[1]  C. Clancy,et al.  Outcomes Research: Measuring the End Results of Health Care , 1998, Science.

[2]  R. Andersen,et al.  Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. , 1998, Health services research.

[3]  Jagdip Singh,et al.  Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. , 1998, Medical care.

[4]  D. Notterman,et al.  Considerations related to the use of recombinant human growth hormone in children , 1997 .

[5]  Jagdip Singh,et al.  Short stature and growth hormone therapy. A national study of physician recommendation patterns. , 1996, JAMA.

[6]  C D Naylor,et al.  Using a Trade-off Technique to Assess Patients' Treatment Preferences for Benign Prostatic Hyperplasia , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  S. Melmed,et al.  Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. , 1995, The Journal of clinical endocrinology and metabolism.

[8]  D A Bloch,et al.  Minimum Data Needed on Patient Preferences for Accurate, Efficient Medical Decision Making , 1995, Medical care.

[9]  R. Greene,et al.  Methodological Challenges and Innovations in Patient Outcomes Research , 1994, Medical care.

[10]  T. Randall.  Producers of videodisc programs strive to expand patient's role in medical decision-making process. , 1993, JAMA.

[11]  S. Kaplan.  The future of patient input into medical decision making. , 1992, QRB. Quality review bulletin.

[12]  L. Underwood.  Growth hormone therapy for short stature: yes or no? , 1992, Hospital practice.

[13]  J. Lantos,et al.  Ethical issues in growth hormone therapy. , 1989, JAMA.

[14]  D. Morgan.  Focus groups for qualitative research. , 1988, Hospital guest relations report.

[15]  J. Tanner,et al.  Clinical longitudinal standards for height and height velocity for North American children. , 1985, The Journal of pediatrics.

[16]  M. Becker,et al.  Effects of sociodemographic and attitudinal factors on mother-initiated medication behavior for children. , 1982, Public health reports.

[17]  R. Hintz.  Growth hormone treatment of idiopathic short stature. , 1996, Hormone research.

[18]  L. Fallowfield,et al.  Offering choice of treatment to patients with cancers. A review based on a symposium held at the 10th annual conference of The British Psychosocial Oncology Group, December 1993. , 1995, European journal of cancer.

[19]  Mary M. Lee.  Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. , 1995, The Journal of pediatrics.

[20]  B. Lippe,et al.  Conventional and nonconventional uses of growth hormone. , 1993, Recent progress in hormone research.